Paul-Ehrlich-Institut

To the Navigation

• In­sti­tute

  Unternavigationspunkte

  • Of­fi­cial Du­ties
  • Guid­ing Prin­ci­ples
  • Or­gan­i­sa­tion
  • ZEPAI
  • PEI In­ter­na­tion­al
  • WHO Col­lab­o­rat­ing Cen­tres
  • His­to­ry of the Paul-Ehrlich-In­sti­tut
  • Por­trait of Paul Ehrlich
  • Bi­ol­o­gy As­so­ci­a­ton

• Medic­i­nal Prod­ucts

  Unternavigationspunkte

  • Vac­cines
  • Al­ler­gens
  • An­ti­bod­ies
  • ATMP
  • Blood Prod­ucts
  • Stem Cell Prepa­ra­tions
  • Tis­sue Prepa­ra­tions
  • Oth­ers (Hu­man Use)
  • Im­muno­log­i­cal Vet­eri­nary Medicines

• Medicine Safe­ty

  Unternavigationspunkte

  • Phar­ma­covig­i­lance
  • Haemovig­i­lance
  • Tis­sue Vig­i­lance
  • Vig­i­lance of In Vit­ro Di­ag­nos­tics (IVD)
  • ATMP Vig­i­lance
  • Phar­ma­covig­i­lance (Vet­eri­nary)
  • Safe­ty In­for­ma­tion (Hu­man)
  • Ed­u­ca­tion­al Ma­te­ri­al

• Reg­u­la­tion

  Unternavigationspunkte

  • Ad­vice
  • Clin­i­cal Tri­als
  • Mar­ket­ing Au­tho­ri­sa­tion (Hu­man)
  • Mar­ket­ing Au­tho­ri­sa­tion (Vet­eri­nary)
  • Ap­provals
  • Batch Test­ing (Hu­man)
  • Batch Test­ing (Vet­eri­nary)
  • In­spec­tions
  • Ref­er­ence Ma­te­ri­al
  • Elec­tron­ic Sub­mis­sion
  • Fees
  • Test­ing Lab­o­ra­to­ry IVD
  • Re­port­ing Obli­ga­tions
  • Qual­i­ty Man­age­ment

• Re­search

  Unternavigationspunkte

  • Re­search Groups
  • Pro­mo­tion of Young Sci­en­tists
  • Re­search and Third-Par­ty Fund­ing
  • Re­search Awards
  • Pub­li­ca­tions

• News­room

  Unternavigationspunkte

  • News
  • Press Re­leas­es
  • Po­si­tions
  • PEI Bi­en­ni­al Re­ports
  • Manda­to­ry Re­ports
  • So­cial Me­dia
  • Events
  • Pub­li­ca­tions on Medicines
  • Videos, Au­dios and In­fo­graph­ics
  • WHO CC An­nu­al Re­ports
  • Cen­tralised Au­tho­ri­sa­tions
  • Coro­n­avirus and COVID-19
  • Brex­it
  • HIV Self-tests
  • No­ti­fi­ca­tions for Med­i­cal and Phar­ma­ceu­ti­cal Pro­fes­sion­als

• Ser­vice

  Unternavigationspunkte

  • Get­ting to PEI
  • Li­brary
  • Ex­ter­nal Ser­vice Provider
  • FAQ
  • Forms
  • Closed Us­er Groups
  • Glos­sary
  • Ca­reer
  • Newslet­ter
  • Press
  • Le­gal As­pects
  • Do­na­tions